Indium-1 1 1 -bleomycin complex (' ' In-BLMC) is a radiopharmaceutical agent that produces tumor regression in mouse glioma in vivo and kills human small cell lung cancer (SCLC) cells in vitro. The interaction between hyperthermia and ' ' 'In-BLMC against human SCLC (N417) cells was studied for bleo
An experimental study of enhanced cell killing by hyperthermia and bleomycin
โ Scribed by Nakajima, K. ;Hisazumi, H.
- Publisher
- Springer
- Year
- 1983
- Tongue
- English
- Weight
- 334 KB
- Volume
- 11
- Category
- Article
- ISSN
- 0300-5623
No coin nor oath required. For personal study only.
โฆ Synopsis
In vitro cell killing effects from heating and/or bleomycin have been investigated using the KK-47 cell line derived from a human bladder carcinoma and the colony-forming assay system. Percent survivals of the asynchronous cells heated to 40 degrees, 41 degrees, 42 degrees and 43 degrees C for 30 min were 96.6%, 93.3%, 91.4% and 71.2%, respectively, and those at 43 degrees C for 2h were 80.6%, 75.5%, 46.0% and 1.4%, respectively. The survival percentages of the cells treated with bleomycin at the concentrations of 1, 3, 6 and 10 micrograms per ml at 37 degrees C for 30 min were 66.0%, 40.4%, 21.9% and 11.9%, respectively. When hyperthermia at 43 degrees C was combined with bleomycin, a greatly enhanced cell killing effect was obtained by preheating and simultaneous heating as compared with the effect of post-heating.
๐ SIMILAR VOLUMES
The interaction between the antibiotic bleomycin and x-radiation has been studied in vitro and in vivo. Tissue culture results appear to reflect in vivo sensitivities correctly. Simultaneous exposure to bleomycin and gamma radiation enhances killing of both sensitive and resistant lines. Data from a